Works matching AU Ji-youn Han

Results: 86
    1
    2
    3
    4

    Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study.

    Published in:
    2021
    By:
    • Park, Keunchil;
    • Jӓnne, Pasi A.;
    • Kim, Dong‐Wan;
    • Han, Ji‐Youn;
    • Wu, Ming‐Fang;
    • Lee, Jong‐Seok;
    • Kang, Jin‐Hyoung;
    • Lee, Dae Ho;
    • Cho, Byoung Chul;
    • Yu, Chong‐Jen;
    • Pang, Yong Kek;
    • Felip, Enriqueta;
    • Kim, Hyunjin;
    • Baek, Eunhye;
    • Noh, Young Su;
    • Kim, Dong-Wan;
    • Han, Ji-Youn;
    • Wu, Ming-Fang;
    • Lee, Jong-Seok;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    5
    6

    Improved Survival Outcomes in Patients With MET Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 7, p. 641, doi. 10.1016/j.cllc.2023.08.011
    By:
    • Wolf, Jurgen;
    • Souquet, Pierre-Jean;
    • Koichi Goto;
    • Cortot, Alexis;
    • Baik, Christina;
    • Heist, Rebecca;
    • Tae Min Kim;
    • Ji-Youn Han;
    • Neal, Joel W.;
    • Mansfield, Aaron S.;
    • Gilloteau, Isabelle;
    • Nwana, Ngozi;
    • Lynch, Maeve Waldron;
    • Davis, Keith L.;
    • Giovannini, Monica;
    • Awad, Mark M.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2459, doi. 10.1007/s00432-021-03527-4
    By:
    • Park, Ji Hyun;
    • You, Gun Lyung;
    • Ahn, Myung-Ju;
    • Kim, Sang-We;
    • Hong, Min Hee;
    • Han, Ji-Youn;
    • Ock, Chan-Young;
    • Lee, Jong-Seok;
    • Oh, In Jae;
    • Lee, Shin Yup;
    • Kim, Cheol Hyeon;
    • Min, Young Joo;
    • Choi, Yoon Hee;
    • Ryu, Jeong-Seon;
    • Park, Sun Hyo;
    • Ahn, Hee Kyung;
    • Shim, Byoung-Yong;
    • Lee, Ki Hyeong;
    • Lee, Sung Yong;
    • Kim, Jin-Soo
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study.

    Published in:
    BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03620-8
    By:
    • Han, Ji-Youn;
    • Ahn, Myung-Ju;
    • Lee, Ki Hyeong;
    • Lee, Yun-Gyoo;
    • Kim, Dong-Wan;
    • Min, Young Joo;
    • Kim, Sang-We;
    • Cho, Eun Kyung;
    • Kim, Joo-Hang;
    • Lee, Gyeong-Won;
    • Lee, Sung Sook;
    • Lee, Na Mi;
    • Jang, Hyun Woo;
    • Han, Heewon;
    • Park, Hyejoo;
    • Lee, Jieon;
    • Cho, Byoung Chul
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.

    Published in:
    Oncogene, 1999, v. 18, n. 25, p. 3754, doi. 10.1038/sj.onc.1202769
    By:
    • Lee, Sug Hyung;
    • Shin, Min Sun;
    • Park, Won Sang;
    • Kim, Su Young;
    • Kim, Ho Sik;
    • Han, Ji Youn;
    • Park, Gyeong Sin;
    • Dong, Seung Myung;
    • Pi, Jae Ho;
    • Kim, Choo Soung;
    • Kim, Sang Ho;
    • Lee, Jung Young;
    • Yoo, Nam Jin
    Publication type:
    Article
    46
    47
    48
    49
    50